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Abstract
Necrotizing enterocolitis (NEC) is one of the deadliest diseases a newborn could contract
while in the neonatal intensive care unit (NICU). NEC is an inflammatory intestinal disease that
is characterized by variable intestinal injury, inflammation and often bacterial invasion
(Alganabi, Lee, Bindi, Li, & Pierro, 2019). This disease affects almost 10% of preterm infants
weighing less than 1500 grams at birth and the mortality rate for infants weighing less than 1000
grams at birth is 30-50%. The pathophysiology of NEC includes a variety of factors and is still
not completely understood. This literature review was written to examine the effects of breast
milk on necrotizing enterocolitis. The literature review contains articles retrieved from online
databases including CINAHL, and PubMed. The literature is still very new on the subject, and
research is still being conducted, however, breast milk appears to play a very important role in
the development of the infant’s intestinal tract.
Keywords: Benefits, breast milk, human milk, necrotizing enterocolitis, preterm infants
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Effects of Breast Milk on Necrotizing Enterocolitis
Early recognition and aggressive treatment have been key factors when improving the
outcomes of infants with necrotizing enterocolitis (NEC) however, this disease still affects
infants across the world. One of the reasons there is a high incidence rate in various hospitals is
the difficulty in defining the condition. In 1978 Dr. Martin Bell developed the first clinical
guidelines for diagnosing NEC called Bell’s Classification or Bell’s Criteria (Gregory, DeForge,
Natale, Phillips & Van Marter, 2011). In the many years since then it has been modified as
technology and medicine have advanced. Bell’s staging criteria use systemic signs, findings in
the abdominal examination and radiographic clues to stratify NEC in three different stages of
increasing severity (Gupta & Paria, 2016). Stage I includes many common clinical conditions
like feed intolerance, non-gut related sepsis and the abdominal features appear very non-specific.
According to Gupta and Paria (2016) in the early stages of NEC, the abdominal features are nonspecific and can manifest as increased prefeed gastric residual volume (GRV), vomiting, mild to
moderate abdominal distension and bloody stools. These symptoms are rather vague and can
point to a wide variety of other conditions. Additionally, more definitive signs such as tenderness
and guarding appear very late, furthering the difficulty of early diagnosis and intervention. There
is also debate between professionals as to what intervention should look like for these infants.
The goal of this literature review is to review an assortment of research-based articles to
determine the effects that breast milk have on preventing and/or treating NEC.
Methods
Included in this literature review are peer reviewed journal articles selected from
keyword searches in online databases including PubMed and CINAHL. Keywords used
included: “necrotizing enterocolitis”, “breast milk and necrotizing enterocolitis”, “effects of
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breast milk on necrotizing enterocolitis”, “human milk and necrotizing enterocolitis”, “donor
human milk and necrotizing enterocolitis”, “mother’s own milk”, “necrotizing enterocolitis in
preterm infants” and “necrotizing enterocolitis in low birth weight infants”. Articles that were
selected were written in English and be published within the last five years.
Effects of Breast Milk on Necrotizing Enterocolitis
All studies included in this literature review have shown that human milk serves a wide
variety of functions for infants including protection against infection, enhancement of
gastrointestinal maturation and dietary nourishment. In addition, the components of breast milk
change to meet the infant’s needs as they grow and it is also believed to help development of the
gastrointestinal system through immunomodulatory as well as antimicrobial actions (Burge,
Hannah, Eckert, Gunasekaran & Chaaban, 2019). There is a group of compounds found in
human milk and on the cell surface of the intestine called glycosaminoglycans (GAGs). One of
the most prominent GAGs in human milk is chondroitin sulfate which comprises about 55% of
the total GAG content (Burge et al., 2019). Research on chondroitin sulfate has shown that the
compound could have antibacterial, antiviral and anti-inflammatory properties. This study tested
the influence of chondroitin sulfate on cell viability, bacterial invasion, bacterial translocation
and the ability of chondroitin sulfate to aid in decreasing intestinal inflammation in the presence
of bacteria. Results showed that even up to concentrations of 750µg/mL, cell viability was not
altered. Additionally, the viability for all concentration test groups remained above 90% after 48
hours of exposure to chondroitin sulfate. There was a dose-dependent reduction in the percent
invasion of bacteria, with the level of bacterial invasion at 750µg/mL of chondroitin sulfate
being significantly lower than the control (Burge et al., 2019). At its highest concentration,
chondroitin sulfate reduced bacterial invasion by 75%. When testing the protection against
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bacterial translocation, researchers found that by the third hour of exposure, the 750µg/mL
solution reduced translocation by about 75%. Overall, this study shows that chondroitin sulfate,
one of the most prominent GAGs in human milk, has the ability to protect against intestinal
infection in an in vitro system, while creating no decrease in cell viability.
The risk of developing NEC at any gestational age may be related to the choice of milk
used, the quantity and the timing of milk introduction (Herrmann & Carroll, 2014). Those three
factors combined are known as feeding practice. This observational single-site study chose a cut
off of 33 weeks gestational age and postmenstrual age (PMA) in which any period younger than
this, and exclusively human milk diet was recommended. Their hypothesis was that for any
infant younger than 33 weeks PMA would receive and exclusively human milk diet and reduce
the incidence of NEC related to enteral feeding. During the study period all of the mothers with
infants in the NICU were encouraged to express their breastmilk with hospital-grade breast
pumps, but when mother’s own milk (MOM) was not enough to meet the infant’s needs,
pasteurized donor human milk (DHM) was obtained from a human milk bank. In order to
prevent any exposure to bovine proteins prior to 33 weeks PMA, human milk was fortified with
a commercial human milk-based product (Herrmann & Carroll, 2014). Infants were receiving
parenteral nutrition until enteral feedings could reach up to 140mL/kg/day. For this study they
defined NEC as stage 2 or higher using Bell’s classification. The EHM cohort included 162
infants and of those 148 (91%) received an EHM diet through 33 weeks PMA. There were 17
cases of NEC in the 443 (3.8%) infants in the control cohort and in seven of 199 (3.5%) in the
EHM cohort. There was a significant reduction of NEC in the EHM cohort for the day of onset
and the PMA at onset. Many NEC occurrences in the EHM cohort presented on day six or seven,
before much enteral milk could be provided. The onset of NEC after day seven, during the
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enteral nutrition phase, was rare for the EHM cohort at only 1% (Herrmann & Carroll, 2014).
This study shows that infants receiving an EHM diet have decreased occurrences of NEC during
the enteral nutrition phase.
Mothers who deliver very low birth weight (VLBW) infants are not as likely to express
their own milk. When challenges are faced regarding obtaining mother’s own milk, the next best
substitute would be donor human milk (DHM). The goal of this study was to examine whether
DHM availability affects breastfeeding rates among VLBW infants and rates of NEC
(Kantorowska et al., 2016). The data for this study was obtained through the California Perinatal
Quality Care Collaborative (CPQCC) which gathers information on the care of >90% of
California’s NICU admissions and VLBW infants as well as the Mothers’ Milk Bank of San Jose
(MMB) which is the largest human milk bank in the United States (Kantorowska et al., 2016).
Results showed that during the study period of 2007-2013, the number of NICU’s receiving
DHM increased from 55 to 133. There was a transition of 22 hospitals that went from having no
DHM to have DHM during the study. These included a variety of care levels being provided and
a total of 10,823 infants being cared for. The mean difference at each hospital was a 10%
increase in breastfeeding at discharge, correlating the introduction of the DHM and the rate of
breastfeeding upon discharge. Among the 22 hospitals that went from no DHM to having DHM
available, the average decrease in NEC was 2.6%. The researchers combined the rates of
breastfeeding at all the hospitals and the combined rate of breastfeeding at discharge increased
from 52.8% to 61.7% after DHM was introduced. They did the same for the rates of NEC after
DHM became available and it decreased from 6.6% to 4.3%. This study shows that the
availability of DHM is linked to improved rates of breastfeeding and decreased rates of NEC.
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Like the previous study, these researchers wanted to look at the rates of NEC related to
DHM, but they completed a single center, observational and retrospective cohort study in the
NICU where they worked. One cohort (Group 1) of 99 infants used premature artificial formula
and the other (including 128 infants) used donor milk (Group 2) if mother’s own milk was
unavailable. Inclusion criteria were infants born at or before 32 completed weeks of gestational
age, admission before 24 hours of life and survival longer than a week. Exclusion criteria were
the presence of major congenital malformations, chromosomal, genetic or metabolic
abnormalities or the absence of clinical records. Group 1 was studied in a two-year time period
before the hospital received DHM and Group 2 was studied in a two-year period after the
hospital received access to DHM. They found that the percentage of children receiving MOM
was the same in both groups and there was a rate of 56.8% for exclusive breastfeeding at
discharge. The incidence of NEC was slightly lower in Group 2 (9.1% vs. 3.4%), especially in
the group with a gestational age between 28 and 32 weeks at birth (Vazquez et al., 2019). It was
also determined that a history of NEC was more frequent among very preterm infants that
eventually died in Group 1. On their unit, since the introduction of the DHM there has been a
decrease in NEC rates, especially in the group of 28-32 weeks at birth. This study supports the
evidence that DHM is a safe and beneficial option for very preterm infants without impairing
their nutrition.
A factor to consider when deciding whether to use human milk or formula while in the
hospital is the cost. A NIH-funded prospective observational cohort study completed by Johnson,
Patel, Bigger, Engstrom and Meier (2015) examined the incidence of NEC, NICU hospitalization
cost and cost of individual resources used during NICU hospitalization. In this study they wanted
to look at using the cost of NEC as a strategy for the exposure period of human milk feedings
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given to VLBW infants during NICU stays. The study took place at Rush University Medical
Center from February 2008-June 2012. They took both direct and indirect costs for the NICU
hospitalization from RUMC’s system-wide cost account system and adjusted them to 2012 USD.
The dose of human milk was calculated as both a weight-adjusted dose (ml/kg/day) and
percentage of enteral feedings equal to human milk (Johnson et al., 2015). It was determined that
the mean total NICU stay cost was 180,163 USD ± 100,824 for infants with NEC and 134,494
USD ± 72,604 for infants without NEC. During the study, 29 of the 291 infants developed NEC.
The infants that developed NEC had longer hospitalizations and higher costs per day. The infants
who had NEC requiring surgery accrued costs more than twice that of medically managed NEC.
After controlling for other variables, NEC was associated with 43,818 USD in additional costs
for the NICU hospitalization (Johnson et al., 2015). After controlling or NEC, each additional
ml/kg/day of human milk in days 1-14 was associated with a reduction of 534 USD in non-NECrelated NICU costs (Johnson et al., 2015). They also discovered that infants with any exposure to
formula during days 1-14 increased their risk of NEC by three times. Researchers also mentioned
that they did not control for other morbidities so it is possible that NEC costs may be even higher
since infants who get NEC have an increased risk for other morbidities.
Strengths and Limitations
The strengths of this literature review include peer reviewed articles that discussed breast
milk as a protective substance against NEC that were submitted within the last five years,
indicating research is current.
Limitations of this literature review include limited access to articles with free access.
There were many articles that could be accessed only through a subscription or payment.
Additionally, many of the articles published on this topic were outside of the five-year inclusion
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range. The articles included in this literature review mention the lack of research on this topic in
recent years and how it lends to the lack of understanding of NEC and possible treatments.
Implications for Practice
The research compiled in this literature review include interventions that can be
implemented without much difficulty. By providing mothers of NICU infants hospital grade
breast pumps, lactation consultants, encouragement and support, many moms could be providing
their baby with breast milk that has protective factors, anti-inflammatory factors and immune
regulating factors. If the mother is unable to provide enough milk, then hospitals can investigate
obtaining DHM from milk banks across the country. This can provide the baby with the nutrients
and assistance that they need to help fight off infections while not negatively impacting
breastfeeding upon discharge.
Implications for Research
NEC is such a multi-faceted condition that requires a lot more research. We are learning a
great deal more about possible treatments, but it still needs to be determined what exactly is
causing this deadly and expensive condition. A study looking at what elements of breastmilk
provide the protection and fight off bacteria in an in vivo system would be very helpful in
determining what we can provide the baby with in the hospital to help them prophylactically.
Discussion
Overall, breastmilk has been shown to have protective factors that help prevent infection
in newborns and that change to meet the baby’s needs as they grow older. Providing infants with
formula may help them grow quicker because it contains specific calorie counts, but it does not
include the factors developed specifically for that baby. In fact, it does not include any protective
factors at all. Formula fed infants will receive the caloric intake necessary, but it could cost them
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a healthy gastrointestinal system. Another factor that many people do not consider when thinking
about formula versus breastmilk, is how it can affect the cost of the hospital stay. To begin with,
the use of breastmilk cuts the cost of formula out of the equation. Also, with the evidence
provided above, mother’s own milk can help protect the baby against infection while formula
does not. If the baby does not contract an infection during their hospitalization, their costs
decreases dramatically. While there is still a great deal of research to be done on what exactly
causes NEC and possible ways to treat it, breastmilk is an effective, easily attainable and safe
option to help boost infants’ immune systems and prevent infections.
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